Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors

Por Chan, Jennifer A., Mayer, Robert J., Jackson, Nadine, Malinowski, Paige, Regan, Eileen, Kulke, Matthew H.
Publicado em 2013